Morschhauser, F., Flinn, I., Gasiorowski, R., Illés, Á., Feugier, P., Greil, R., Johnson, N., Larouche, J., Lugtenburg, P., Patti, C., Salles, G., Trněný, M., de Vos, S., Mir, F., Kornacker, M., Punnoose, E., Samineni, D., Szafer‐Glusman, E., Petrich, A., Sinha, A., Spielewoy, N., Humphrey, K., Bazeos, A., & Zelenetz, A. (n.d.). iMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY. Hematological oncology, 37, 135–137. http://access.bl.uk/ark:/81055/vdc_100086210174.0x000039